Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Neurobiol Dis. 2019 May 31;133:104487. doi: 10.1016/j.nbd.2019.104487

Figure 6.

Figure 6

Kaplan-Meier time-to-event analysis showing cessation of seizure-like behavior in rats challenged with a subcutaneous dosage of the VX surrogate nitrophenyl ethyl methylphosphonate (NEMP; 0.65 mg/kg) followed by 2-PAM or novel oximes alone or in combination with 2-PAM delivered intramuscularly in multisol at 0.146 mmoles/kg at time of initiation of seizure-like behavior (about 30 min post NIMP challenge). Hash marks indicate animal death. Data adapted from data in Chambers et al., 2016b.